Picture of Arcticzymes Technologies ASA logo

AZT Arcticzymes Technologies ASA Share Price

0.000.00%
no flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapFalling Star

Momentum

Relative Strength (%)
1m-5.39%
3m-33.9%
6m-2.77%
1yr-33.24%
Volume Change (%)
10d/3m-65.86%
Price vs... (%)
52w High-40.42%
50d MA-3.6%
200d MA-16.17%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)60.24
PEG Ratio (f)3.01
EPS Growth (f)25.04%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value4.67
Price to Tang. Book5.1
Price to Free Cashflow276.27
Price to Sales12.1
EV to EBITDA57.17

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital5%
Return on Equity6.31%
Operating Margin13.33%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueNOKm45.1993.45127.97136.97118.9412715312.24%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/a-65.42+4.64-11.87+5.41+71.79n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Arcticzymes Technologies ASA EPS forecast chart

Profile Summary

Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
March 12th, 1995
Public Since
November 4th, 2005
No. of Employees
61
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
no flag iconOslo Stock Exchange
Shares in Issue
50,871,390
Blurred out image of a map
Address
Sykehusveien 23, TROMSO, 9019
Web
https://arcticzymes.com/
Phone
+47 77648900
Auditors
PricewaterhouseCoopers AS

AZT Share Price Performance

Upcoming Events for AZT

Q1 2024 Arcticzymes Technologies ASA Earnings Release

Arcticzymes Technologies ASA Annual Shareholders Meeting

Arcticzymes Technologies ASA Annual Shareholders Meeting

Q2 2024 Arcticzymes Technologies ASA Earnings Release

Similar to AZT

Picture of Bergenbio ASA logo

Bergenbio ASA

no flag iconOslo Stock Exchange

Picture of Circio Holding ASA logo

Circio Holding ASA

no flag iconOslo Stock Exchange

Picture of Exact Therapeutics AS logo

Exact Therapeutics AS

no flag iconOslo Stock Exchange

Picture of Lifecare AS logo

Lifecare AS

no flag iconOslo Stock Exchange

Picture of Lytix Biopharma AS logo

Lytix Biopharma AS

no flag iconOslo Stock Exchange

FAQ